Synergistic Combinations of Multiple Chemotherapeutic Agents in High Capacity Poly(2-oxazoline) Micelles
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Many effective drugs for cancer treatment are poorly water-soluble. In combination chemotherapy, needed excipients in additive formulations are often toxic and restrict their applications in clinical intervention. Here, we report on amphiphilic poly(2-oxazoline)s (POx) micelles as a promising high capacity delivery platform for multidrug cancer chemotherapy. A variety of binary and ternary drugs combinations of paclitaxel (PTX), docetaxel (DTX), 17-allylamino-17-demethoxygeldanamycin (17-AAG), etoposide (ETO) and bortezomib (BTZ) were solubilized in defined polymeric micelles achieving unprecedented high total loading capacities of up to 50 wt % drug per final formulation. Multidrug loaded POx micelles showed enhanced stability in comparison to single-drug loaded micelles. Drug ratio dependent synergistic cytotoxicity of micellar ETO/17-AAG was observed in MCF-7 cancer cells and of micellar BTZ/17-AAG in MCF-7, PC3, MDA-MB-231 and HepG2 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A number of other hydrophobic drugs such as etoposide, 3rd generation of taxanes, and vismodegib as well as multiple drug combinations were shown to be solubilized in the POx micelle system with high loading [113, 117, 118].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Han et al. reported the synergistic solubilization of multiple drugs in a single micelle system with high LC resulting in formation of ultra-high loaded polymeric micelle drug formulations.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For many drugs, the aqueous POx micelle solutions can be readily prepared that contain 10 to 50 g/L of extremely poorly soluble drug and are stable for days and weeks.”
From Co-delivery of Paclitaxel and Cisplatin in Poly(2-oxazoline) Polymeric Micelles: Implications for Drug Loading, Release, Pharmacokinetics and Outcome of Ovarian and Breast Cancer Treatments (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, PTX POx micelles have ca. 4 to 100 times higher drug loading and ca. 10 to 20 times higher drug concentration than the current PTX clinical formulations Taxol, Genexol-PM, and Abraxane.”
From Co-delivery of Paclitaxel and Cisplatin in Poly(2-oxazoline) Polymeric Micelles: Implications for Drug Loading, Release, Pharmacokinetics and Outcome of Ovarian and Breast Cancer Treatments (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The solubility of these drugs in POx micelles system is increased by a factor of 1,000 to 100,000 times.”
From Co-delivery of Paclitaxel and Cisplatin in Poly(2-oxazoline) Polymeric Micelles: Implications for Drug Loading, Release, Pharmacokinetics and Outcome of Ovarian and Breast Cancer Treatments (2019) · cites this paper as [13]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sain, N., Krishnan, B., Ormerod, M. G., Rienzo, A. D., Liu, W. M., Kaye, S. B., Workman, P., & Jackman, A. L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0445 · Cited by 92
RetractedProspective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
The proteasome: a suitable antineoplastic target
Adams, J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1361 · Cited by 1,201
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Etoposide: four decades of development of a topoisomerase II inhibitor
Hande, K. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00228-7 · Cited by 949
Stem Cells and Cancer: Two Faces of Eve
Clarke, M. F., & Fuller, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.011 · Cited by 905
The proteasome inhibitor PS-341 in cancer therapy.
Teicher, B. A., Ara, G., Herbst, R. S., Palombella, V. J., & Adams, J. (1999) · PubMed · Cited by 521
Poly (2-oxazoline) s as polymer therapeutics
Luxenhofer, R., Han, Y., Schulz, A., Tong, J., He, Z., Kabanov, A. V., & Jordan, R. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200354 · Cited by 470
Self-citationPolyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
Viegas, T. X., Bentley, M. D., Harris, J. M., Fang, Z., Yoon, K., Dizman, B., Weimer, R., Mero, A., Pasut, G., & Veronese, F. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200049d · Cited by 432
Barz, M., Luxenhofer, R., Zentel, R., & Vicent, M. J. (2011) · Polymer Chemistry · doi:10.1039/c0py00406e · Cited by 418
Self-citationPersidis, A. (1999) · Nature Biotechnology · doi:10.1038/5289 · Cited by 372
Woodle, M. C., Engbers, C. M., & Zalipsky, S. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00030a001 · Cited by 361
Novel formulations of taxanes: a review. Old wine in a new bottle?
Hennenfent, K. L., & Govindan, R. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj100 · Cited by 345
Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Bally, M. B., & Janoff, A. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0118 · Cited by 331
Evaluation of Blood Clearance Rates and Biodistribution of Poly(2-oxazoline)-Grafted Liposomes§
Zalipsky, S., Hansen, C. B., Oaks, J. M., & Allen, T. M. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9504043 · Cited by 314
Kabanov, A. V., Chekhonin, V. P., Alakhov, V. Y., Batrakova, E. V., Lebedev, A. S., Melik-Nubarov, N. S., Arzhakov, S. A., Levashov, A. V., Morozov, G. V., Severin, E. S., et al. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81689-8 · Cited by 296
Self-citationDoubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs
Luxenhofer, R., Schulz, A., Roques, C., Li, S., Bronich, T. K., Batrakova, E. V., Jordan, R., & Kabanov, A. V. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.057 · Cited by 286
Self-citationSong, X., Zhao, Y., Wu, W., Bi, Y., Cai, Z., Chen, Q., Li, Y., & Hou, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.034 · Cited by 282
Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s
Gaertner, F. C., Luxenhofer, R., Blechert, B., Jordan, R., & Essler, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.015 · Cited by 255
Self-citationKobayashi, S. (1990) · Progress in Polymer Science · doi:10.1016/0079-6700(90)90011-o · Cited by 245
Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs
Shin, H.-C., Alani, A. W. G., Rao, D. A., Rockich, N. C., & Kwon, G. S. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.024 · Cited by 243
Grem, J. L., Morrison, G., Guo, X.-D., Agnew, E., Takimoto, C. H., Thomas, R., Szabo, E., Grochow, L., Grollman, F., Hamilton, J. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.085 · Cited by 242
Solid-State Characterization of Paclitaxel
Liggins, R. T., Hunter, W. L., & Burt, H. M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9605226 · Cited by 224
Optimizing Combination Chemotherapy by Controlling Drug Ratios
Mayer, L. D., & Janoff, A. S. (2007) · Molecular Interventions · doi:10.1124/mi.7.4.8 · Cited by 214
Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles
Luxenhofer, R., Sahay, G., Schulz, A., Alakhova, D., Bronich, T. K., Jordan, R., & Kabanov, A. V. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.010 · Cited by 212
Self-citationPark, J.-S., & Kataoka, K. (2007) · Macromolecules · doi:10.1021/ma0701181 · Cited by 211
Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer
Solit, D. B., Ivy, S. P., Kopil, C., Sikorski, R., Morris, M. J., Slovin, S. F., Kelly, W. K., DeLaCruz, A., Curley, T., Heller, G., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1863 · Cited by 211
Mimnaugh, E. G., Xu, W., Vos, M., Yuan, X., Isaacs, J. S., Bisht, K. S., Gius, D., & Neckers, L. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.551.3.5 · Cited by 210
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
Solit, D. B., Osman, I., Polsky, D., Panageas, K. S., Daud, A., Goydos, J. S., Teitcher, J., Wolchok, J. D., Germino, F. J., Krown, S. E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1002 · Cited by 190
Click Chemistry with Poly(2-oxazoline)s
Luxenhofer, R., & Jordan, R. (2006) · Macromolecules · doi:10.1021/ma052515m · Cited by 188
Self-citationCombinatorial Drug Conjugation Enables Nanoparticle Dual‐Drug Delivery
Aryal, S., Hu, C. J., & Zhang, L. (2010) · Small · doi:10.1002/smll.201000631 · Cited by 183
Solubility and miscibility of poly(ethyl oxazoline)
Lin, P., Clash, C., Pearce, E. M., Kwei, T. K., & Aponte, M. A. (1988) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.1988.090260312 · Cited by 183
Modulation of the lower critical solution temperature of 2-Alkyl-2-oxazoline copolymers
Huber, S., & Jordan, R. (2008) · Colloid and Polymer Science · doi:10.1007/s00396-007-1781-y · Cited by 174
Self-citationSolomatin, S. V., Bronich, T. K., Bargar, T. W., Eisenberg, A., Kabanov, V. A., & Kabanov, A. V. (2003) · Langmuir · doi:10.1021/la030015l · Cited by 134
Self-citationA 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs
Shin, H.-C., Alani, A. W. G., Cho, H., Bae, Y., Kolesar, J. M., & Kwon, G. S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2000549 · Cited by 126
Bonné, T. B., Lüdtke, K., Jordan, R., Štěpánek, P., & Papadakis, C. M. (2004) · Colloid & Polymer Science · doi:10.1007/s00396-004-1131-2 · Cited by 90
Self-citationWong, M.-Y., & Chiu, G. N. C. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328336e940 · Cited by 90
Ramanathan, R. K., Egorin, M. J., Eiseman, J. L., Ramalingam, S. S., Friedland, D., Agarwala, S. S., Ivy, S. P., Potter, D. M., Chatta, G. S., Zuhowski, E. G., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2233 · Cited by 87
Synthesis and Aqueous Micellization of Amphiphilic Tetrablock Ter- and Quarterpoly(2-oxazoline)s
Hoogenboom, R., Wiesbrock, F., Leenen, M. A. M., Thijs, H. M. L., Huang, H., Fustin, C., Guillet, P., Gohy, J., & Schubert, U. S. (2007) · Macromolecules · doi:10.1021/ma062725e · Cited by 85
Bonné, T. B., Lüdtke, K., Jordan, R., & Papadakis, C. M. (2007) · Macromolecular Chemistry and Physics · doi:10.1002/macp.200700140 · Cited by 80
Self-citationNguyen, D. M., Lorang, D., Chen, G. A., Stewart, J. H., Tabibi, E., & Schrump, D. S. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(01)02787-4 · Cited by 78
Yao, Q., Weigel, B. J., & Kersey, J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1750 · Cited by 75
Static and Dynamic Swelling of Grafted Poly(2-alkyl-2-oxazoline)s
Rehfeldt, F., Tanaka, M., Pagnoni, L., & Jordan, R. (2002) · Langmuir · doi:10.1021/la0112559 · Cited by 62
Self-citationAqueous solutions of poly(ethyloxazoline) and its lower consolute phase transition
Chen, F. P., Ames, A. E., & Taylor, L. D. (1990) · Macromolecules · doi:10.1021/ma00223a029 · Cited by 61
Ivanova, R., Komenda, T., Bonné, T. B., Lüdtke, K., Mortensen, K., Pranzas, P. K., Jordan, R., & Papadakis, C. M. (2008) · Macromolecular Chemistry and Physics · doi:10.1002/macp.200800232 · Cited by 59
Self-citationForeman, M. B., Coffman, J. P., Murcia, M. J., Cesana, S., Jordan, R., Smith, G. S., & Naumann, C. A. (2002) · Langmuir · doi:10.1021/la0261390 · Cited by 56
Self-citationRational Design of Cancer-Drug Combinations
Ramaswamy, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmcibr072593 · Cited by 48
Reddy, N. M., & Czuczman, M. S. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq009 · Cited by 40
Baekmark, T. R., Sprenger, I., Ruile, M., Nuyken, O., & Merkel, R. (1998) · Langmuir · doi:10.1021/la970601c · Cited by 23
Zhao, M., Hu, F., Du, Y., Yuan, H., Chen, F., Lou, Y.-M., & He-yong, Y. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/5/055102 · Cited by 23
Li, X., Rasouli, P., & Ruden, D. M. (2006) · Current Medicinal Chemistry · doi:10.2174/092986707779313372 · Cited by 21
Micellar structure of amphiphilic poly(2-oxazoline) diblock copolymers
Papadakis, C. M., Ivanova, R., Lüdtke, K., Mortensen, K., Pranzas, P. K., & Jordan, R. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889806056184 · Cited by 15
Self-citationMicellization of Poly(2‐oxazoline)‐Based Quasi‐Diblock Copolymers on Surfaces
Fustin, C., Lefèvre, N., Hoogenboom, R., Schubert, U. S., & Gohy, J. (2007) · Macromolecular Chemistry and Physics · doi:10.1002/macp.200700231 · Cited by 15
Research works printed but not linked: 1
- Teicher B. A., 1999, Clin. Cancer Res., 5, 2638
Cited by
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
Self-citationPolymeric micelles in cancer therapy: State of the art
Ghosh, B., & Biswas, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.016 · Cited by 546
Polymeric nanoparticles: the future of nanomedicine
Banik, B. L., Fattahi, P., & Brown, J. L. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1364 · Cited by 485
Poly (2-oxazoline) s as polymer therapeutics
Luxenhofer, R., Han, Y., Schulz, A., Tong, J., He, Z., Kabanov, A. V., & Jordan, R. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200354 · Cited by 470
Self-citation
Metadata
- Authors
- Han, Y., He, Z., Schulz, A., Bronich, T. K., Jordan, R., Luxenhofer, R., & Kabanov, A. V.
- Affiliations
- Wuhan University of Technology (CN)
- University of Nebraska Medical Center (US)
- Technische Universität Dresden (DE)
- Lomonosov Moscow State University (RU)
- Corresponding author
- Luxenhofer, Robert
- Kabanov, Alexander V.
- ORCID
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-06-28
- Volume
- 9
- Issue
- 8
- Pages
- 2302-2313
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- PMC
- PMC3534837
- OpenAlex
- W2027018089
- Semantic Scholar
- 01a9d840f24848c24560e63ca4db63dfc02015e0
- Cited by
- 125
- References
- 59
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 12 · 2013: 8 · 2012: 4
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U01 CA116591, U01CA151806, R01CA116591, P30CA036727)
- National Institute of General Medical Sciences (P20GM103480)
- National Center for Research Resources (RR-021937, P20RR021937)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Surfactants and Colloidal Systems
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- combination chemotherapy, drug loading capacity, paclitaxel, docetaxel, 17-AAG, etoposide, bortezomib, synergistic cytotoxicity, poorly water-soluble drugs, drug solubilization, MCF-7 cells
- MeSH terms
- Docetaxel, Antineoplastic Agents, Cell Survival, Drug Carriers, Etoposide, Humans, Micelles, Oxazoles, Benzoquinones, Drug Delivery Systems, Taxoids, Cell Line, Tumor, Lactams, Macrocyclic, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.